BNY vs IBKR vs USB
161 measures in 16 categories, one definition each, computed from filings and market data.
BNY54.3
Bank of New York Mellon Corp
Financial Services · Investment - Banking & Investment Services
$143.24 +0.82%$97.2B mkt cap
Score DNA
IBKR56.4
Interactive Brokers Group, Inc.
Financial Services · Investment - Banking & Investment Services
$82.69 −3.88%$145.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
BNY IBKR USB · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry (these stocks sit in different industries). n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 6 | 0 |
| Insider $ bought, 180d | — | $0.01M | — |
| Congress purchases, 180d | 0 | 0 | 1 |
| Last Congress purchase | — | — | 2026-06-02 |
| 13F net change in holders | — | +118 | +91 |
| ETFs adding shares, 30d | 1,348 | 1,099 | 1,547 |
| ETFs trimming, 30d | 1,293 | 777 | 1,204 |
| Net ETF funds, 30d | +55 | +322 | +343 |
Valuation
16 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| P/E (TTM) | 20.0x
50th
|
129.1x
100th
|
11.2x
40th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.33 | 4.75 | 0.96
27th
|
| Price / sales | 3.2x
50th
|
13.1x
100th
|
2.1x
21st
|
| Price / book | 2.2x
0th
|
24.6x
100th
|
1.4x
71st
|
| Price / tangible book | 4.0x
0th
|
6.6x
50th
|
1.9x
81st
|
| Price / free cash flow | n/a | n/a | n/a |
| Price / operating cash flow | n/a | n/a | n/a |
| Enterprise value | n/a | n/a | n/a |
| EV / sales | n/a | n/a | n/a |
| EV / EBITDA | n/a | n/a | n/a |
| EV / EBIT | n/a | n/a | n/a |
| EV / free cash flow | n/a | n/a | n/a |
| Earnings yield | 5.0%
50th
|
0.8%
0th
|
8.9%
61st
|
| FCF yield | n/a | n/a | n/a |
| Operating cash flow yield | n/a | n/a | n/a |
| Graham number (per share) | $100.01
100th
|
$27.17
0th
|
$71.62
72nd
|
Profitability (TTM)
12 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Gross margin | n/a | n/a | n/a |
| EBITDA margin | n/a | n/a | n/a |
| Operating margin | 20.3%
0th
|
87.1%
100th
|
23.9%
45th
|
| EBIT margin | 20.3%
0th
|
87.6%
100th
|
23.3%
39th
|
| Net margin | 16.1%
100th
|
10.1%
0th
|
18.7%
25th
|
| NOPAT margin | 16.2%
25th
|
79.6%
100th
|
19.2%
47th
|
| FCF margin | n/a | n/a | n/a |
| Operating cash flow margin | n/a | n/a | n/a |
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 24.8%
100th
|
4.1%
25th
|
32.0%
71st
|
| Stock comp / revenue | 0.0%
0th
|
1.1%
25th
|
0.0%
0th
|
| Effective tax rate | 20.2%
50th
|
8.6%
0th
|
19.7%
31st
|
Returns on capital
11 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| ROE (on average equity) | 21.6%
50th
|
21.0%
25th
|
12.7%
71st
|
| ROA | 1.8%
25th
|
0.5%
0th
|
1.2%
41st
|
| ROIC | n/a | n/a | n/a |
| ROCE | n/a | n/a | n/a |
| Return on tangible assets | 2.3%
0th
|
4.5%
25th
|
1.4%
49th
|
| Cash ROIC (OCF / invested capital) | n/a | n/a | n/a |
| Gross profitability (GP / assets) | n/a | n/a | n/a |
| ROIC, 3-yr average | n/a | n/a | n/a |
| ROIC, 5-yr average | n/a | n/a | n/a |
| ROE, 5-yr average | 2.6%
0th
|
16.0%
25th
|
11.5%
64th
|
| Incremental ROIC | n/a | n/a | n/a |
Growth
17 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Revenue growth (TTM YoY) | — | 15.8% | 3.3%
47th
|
| Revenue growth (QoQ) | 3.3%
25th
|
9.3%
75th
|
0.8%
42nd
|
| Revenue CAGR, 3 yr | 962.9%
100th
|
20.8%
75th
|
7.8%
33rd
|
| Revenue CAGR, 5 yr | 307.5%
100th
|
32.6%
75th
|
12.7%
44th
|
| Gross profit CAGR, 3 yr | n/a | n/a | n/a |
| Operating income CAGR, 3 yr | 566.2%
100th
|
23.5%
50th
|
12.8%
78th
|
| Net income growth (TTM YoY) | — | 34.4% | 18.4%
40th
|
| Net income CAGR, 3 yr | 507.5%
100th
|
30.4%
25th
|
12.1%
70th
|
| EPS growth (TTM YoY) | 1,703.2%
100th
|
31.8%
50th
|
18.8%
46th
|
| EPS CAGR, 3 yr | 60.9%
100th
|
27.2%
50th
|
11.6%
82nd
|
| EPS CAGR, 5 yr | 19.2%
75th
|
23.9%
100th
|
1.2%
24th
|
| FCF growth (TTM YoY) | n/a | n/a | n/a |
| FCF CAGR, 3 yr | n/a | n/a | n/a |
| Operating cash flow CAGR, 3 yr | n/a | n/a | n/a |
| Book value CAGR, 3 yr | 61.8%
100th
|
20.2%
50th
|
7.8%
38th
|
| Dividend CAGR, 3 yr | 3.4%
75th
|
5.6%
100th
|
0.3%
42nd
|
| Sustainable growth rate | 15.8%
50th
|
18.2%
75th
|
7.2%
41st
|
Margin history & stability
7 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Gross margin, 3-yr average | n/a | n/a | n/a |
| Operating margin, 3-yr average | 62.0%
75th
|
85.3%
100th
|
20.1%
34th
|
| Net margin, 3-yr average | -20.3%
0th
|
8.9%
25th
|
15.8%
23rd
|
| FCF margin, 3-yr average | n/a | n/a | n/a |
| Revenue stability (0-1) | 0.41
25th
|
0.99
100th
|
0.90
50th
|
| Earnings stability (0-1) | 0.42
50th
|
0.93
100th
|
0.04
19th
|
| Margin stability (0-1) | 0.76
0th
|
0.93
75th
|
0.79
34th
|
Liquidity (latest quarter)
7 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Cash & short-term investments | n/a | n/a | n/a |
| Net cash (− = net debt) | n/a | n/a | n/a |
| Working capital | n/a | n/a | n/a |
| Current ratio | n/a | n/a | n/a |
| Quick ratio | n/a | n/a | n/a |
| Cash ratio (cash + ST investments / current liabilities) | n/a | n/a | n/a |
| Defensive interval (days) | n/a | n/a | n/a |
Leverage & solvency (latest quarter)
13 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Total debt | n/a | n/a | n/a |
| Debt / equity | n/a | n/a | n/a |
| Net debt / equity | n/a | n/a | n/a |
| Debt / assets | n/a | n/a | n/a |
| Debt / capital | n/a | n/a | n/a |
| Debt / EBITDA | n/a | n/a | n/a |
| Net debt / EBITDA | n/a | n/a | n/a |
| Interest coverage (EBIT / interest) | n/a | n/a | n/a |
| Cash interest coverage | n/a | n/a | n/a |
| Debt payback (years of OCF) | n/a | n/a | n/a |
| Liabilities / assets | 91.4%
100th
|
91.0%
75th
|
90.6%
85th
|
| IS credit model rating | B+ | BB | A |
| Implied credit spread (bps) | 650
100th
|
475
75th
|
150
42nd
|
Efficiency
11 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Asset turnover | n/a | n/a | n/a |
| Fixed asset turnover | n/a | n/a | n/a |
| Inventory turnover | n/a | n/a | n/a |
| Receivables turnover | n/a | n/a | n/a |
| Days sales outstanding | n/a | n/a | n/a |
| Days inventory outstanding | n/a | n/a | n/a |
| Days payables outstanding | n/a | n/a | n/a |
| Cash conversion cycle (days) | n/a | n/a | n/a |
| Capex / revenue | n/a | n/a | n/a |
| Capex / depreciation | n/a | n/a | n/a |
| Operating expense ratio | n/a | n/a | n/a |
Cash flow & earnings quality
7 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Operating cash flow / net income | n/a | n/a | n/a |
| FCF / net income | n/a | n/a | n/a |
| FCF / operating cash flow | n/a | n/a | n/a |
| Capex / operating cash flow | n/a | n/a | n/a |
| Accruals ratio | n/a | n/a | n/a |
| Sloan accruals ratio | n/a | n/a | n/a |
| Earnings quality score (0-1) | n/a | n/a | n/a |
Scores & forensic checks
15 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| IS score | 54
0th
|
56
25th
|
59
70th
|
| IS profitability | 63
50th
|
66
75th
|
62
51st
|
| IS growth | 78
50th
|
70
25th
|
55
48th
|
| IS value | 64
75th
|
49
0th
|
83
61st
|
| IS momentum | 91
25th
|
94
50th
|
83
66th
|
| IS risk (safety) | 15
0th
|
30
25th
|
65
37th
|
| IS quality | 68
25th
|
58
0th
|
76
52nd
|
| IS balance sheet | 57
25th
|
51
0th
|
39
24th
|
| IS earnings quality | 67
50th
|
61
25th
|
99
91st
|
| IS cash flow | 56
0th
|
81
50th
|
83
77th
|
| Piotroski F-score (0-9) | 5
25th
|
6
75th
|
8
82nd
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −7.87
100th
|
−8.06
75th
|
−7.09
0th
|
| IS credit score | 33
0th
|
42
25th
|
70
50th
|
Size (TTM)
8 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| Market cap | $97.2B
75th
|
$145.3B
100th
|
$91.5B
100th
|
| Revenue | $30.1B
100th
|
$11.1B
75th
|
$43.7B
100th
|
| EBITDA | $7.5B
75th
|
$9.8B
100th
|
$11.0B
100th
|
| Net income | $4.9B
100th
|
$1.1B
75th
|
$8.2B
100th
|
| Free cash flow | n/a | n/a | n/a |
| Total assets | $525.0B
100th
|
$247.3B
75th
|
$725.9B
100th
|
| Shareholders' equity | $44.7B
100th
|
$5.9B
75th
|
$67.4B
100th
|
| Employees | 46,500
100th
|
3,265
75th
|
68,520
100th
|
Price performance
9 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| 1 day | +0.8% | −3.9% | +2.3% |
| 1 week | +0.4% | −5.9% | +2.9% |
| 1 month | −6.4% | −6.4% | −1.6% |
| 3 months | −8.4% | −9.8% | −7.0% |
| 6 months | +1,305.8% | +1.2% | +3.1% |
| Year to date | +8.1% | +23.1% | +8.9% |
| 1 year | +1,432.1% | +18.7% | +26.4% |
| 3 years, cumulative | +1,522.3% | +283.0% | +97.6% |
| 5 years, cumulative | +1,103.8% | +372.5% | +13.0% |
Technicals
4 measures| Measure | BNY | IBKR | USB |
|---|---|---|---|
| RSI 14 | 39.8 | 37.6 | 51.2 |
| From 52-week high | −13.6% | −16.2% | −11.1% |
| From 52-week low | +1,472.5% | +40.5% | +30.4% |
| Beta | 1.05 | 1.37 | 0.97 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17